RICHMOND MARK 4
4 · OSI PHARMACEUTICALS INC · Filed Jan 5, 2005
Insider Transaction Report
Form 4
RICHMOND MARK
Director
Transactions
- Sale
Common Stock
2005-01-03$73.53/sh−384$28,236→ 3,837 total - Sale
Common Stock
2005-01-03$73.95/sh−94$6,951→ 3,540 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-01-03−1,500→ 32,000 totalExercise: $16.81From: 2000-04-10Exp: 2010-04-09→ Common Stock (1,500 underlying) - Sale
Common Stock
2005-01-03$74.40/sh−22$1,637→ 3,476 total - Sale
Common Stock
2005-01-03$74.41/sh−18$1,339→ 3,458 total - Sale
Common Stock
2005-01-03$74.47/sh−492$36,639→ 2,936 total - Sale
Common Stock
2005-01-03$74.05/sh−30$2,222→ 3,510 total - Sale
Common Stock
2005-01-03$73.52/sh−169$12,425→ 4,221 total - Sale
Common Stock
2005-01-03$73.65/sh−188$13,846→ 3,634 total - Exercise/Conversion
Common Stock
2005-01-03$16.81/sh+1,500$25,220→ 4,390 total - Sale
Common Stock
2005-01-03$73.60/sh−11$810→ 3,826 total - Sale
Common Stock
2005-01-03$73.62/sh−4$294→ 3,822 total - Sale
Common Stock
2005-01-03$74.50/sh−38$2,831→ 2,898 total - Sale
Common Stock
2005-01-03$74.10/sh−8$593→ 3,502 total - Sale
Common Stock
2005-01-03$74.42/sh−26$1,935→ 3,432 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Exercisable as to 25,000 shares on 04/10/2000 and the remainder on 04/10/2001.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.